Midazolam and Micafungin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Midazolam (midazolam) and Micafungin (micafungin sodium). Common drug interactions include systemic inflammatory response syndrome among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Midazolam and Micafungin. It is created by eHealthMe based on reports of 97 people who take the same drugs from the FDA, and is updated regularly.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

What is Micafungin?

Micafungin has active ingredients of micafungin sodium. eHealthMe is studying from 6,562 Micafungin users. Check the latest studies of Micafungin.

On Jul, 03, 2026

97 people who take Midazolam and Micafungin together, and have interactions are studied.

Midazolam and Micafungin drug interactions.

What are the common drug interactions of Midazolam and Micafungin, by gender? *:

female:

Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Cardiac tamponade (fluid accumulates in heart covering)
Colitis (inflammation of colon)
Respiratory distress (difficulty in breathing)
Respiratory failure (inadequate gas exchange by the respiratory system)
Alanine aminotransferase increased
Anaemia (lack of blood)
Aspartate aminotransferase increased
Blood bilirubin increased

male:

Pneumonia
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Haemoglobin decreased
Pancreatitis acute (sudden inflammation of pancreas)
Polyomavirus-associated nephropathy (polyomavirus-associated kidney disease)
Respiratory failure (inadequate gas exchange by the respiratory system)
White blood cell count decreased
Febrile neutropenia (fever with reduced white blood cells)
Bilirubin conjugated increased
Blood creatinine increased

What are the common drug interactions of Midazolam and Micafungin, by age (0-1 to 60+)? *:

0-1:

Intraventricular haemorrhage (intraventricular bleeding)
Bilirubin conjugated increased
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Retinopathy of prematurity (retina damage in premature)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
White blood cell count increased
Anaemia (lack of blood)
Blood creatinine increased
Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

2-9:

Haematuria (presence of blood in urine)
Blood creatine phosphokinase increased
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Paronychia (infection in the tissues adjacent to a nail on a finger or toe)
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Upper respiratory tract infection
Haemolytic anaemia (anaemia due to haemolysis)
Renal impairment (severely reduced kidney function)

10-19:

Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Haemoglobin decreased
Pancreatitis acute (sudden inflammation of pancreas)
Platelet count decreased
Polyomavirus-associated nephropathy (polyomavirus-associated kidney disease)
Renal impairment (severely reduced kidney function)
White blood cell count decreased
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Biliary colic
Candida sepsis (candida in blood stream)

20-29:

Decreased appetite
Pyrexia (fever)
Acquired immunodeficiency syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv))
Cytomegalovirus infection
Depressed level of consciousness
Epstein-barr virus infection
Hyperbilirubinaemia (excess of bilirubin in the blood)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Liver disorder (liver diseases)
Lymphoma (cancer that begins in immune system cells)

30-39:

n/a

40-49:

Pneumonia
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Sepsis (a severe blood infection that can lead to organ failure and death)
Arrhythmia (irregular heartbeat)
Bacterial infection
Blood creatinine increased
Cardiac failure
Coagulopathy (blood's ability to clot is impaired)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)

50-59:

Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Leukocytosis (increased white blood cells)
Loss of consciousness
Pco2 decreased
Po2 increased
Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
Red blood cell count decreased
Respiratory disorder (respiratory disease)
Septic shock (shock due to blood infection)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

60+:

Pneumonia
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Hepatic failure (liver failure)
Pericardial effusion (fluid around the heart)
Aphasia (damage to the parts of the brain that control language)
Bacteraemia (presence of bacteria in the blood)
Cytomegalovirus viraemia (cytomegalo virus in blood stream)
Death
Encephalopathy (functioning of the brain is affected by some agent or condition)
Fungaemia (fungi circulate in the blood)

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 13 people, 13.40%
Sedation: 11 people, 11.34%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 10 people, 10.31%
High Blood Pressure: 10 people, 10.31%
Nausea (feeling of having an urge to vomit): 8 people, 8.25%
Hyperglycemia (high blood sugar): 7 people, 7.22%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 7.22%
Hiv Infection: 6 people, 6.19%
Fever: 6 people, 6.19%
Diabetes: 6 people, 6.19%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam and Micafungin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously